3-amino-pyrrolo[3,4-c] pyrazole5 (1H, 4H, 6H) carbaldehyde derivatives as PKC inhibitors

Details for Australian Patent Application No. 2008212625 (hide)

Owner Pfizer Inc.

Inventors Yin, Chunfeng; Nukui, Seiji; Teng, Min; Scales, Stephanie Anne; Li, Hui

Agent Spruson & Ferguson

Pub. Number AU-B-2008212625

PCT Pub. Number WO2008/096260

Priority 61/020,965 14.01.08 US; 60/989,086 19.11.07 US; 60/888,749 07.02.07 US

Filing date 4 February 2008

Wipo publication date 14 August 2008

Acceptance publication date 19 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4162 - condensed with heterocyclic ring systems

A61P 3/00 Drugs for disorders of the metabolism

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/096260 Priority application(s): WO2008/096260

19 July 2012 Application Accepted

  Published as AU-B-2008212625

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212632-Glazing panel

2008212622-An improved process for preparation of rosuvastatin calcium